301 related articles for article (PubMed ID: 35205318)
1. Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection.
Gibson MS; Noronha-Estima C; Gama-Carvalho M
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205318
[TBL] [Abstract][Full Text] [Related]
2. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.
Swaminathan S; Suzuki K; Seddiki N; Kaplan W; Cowley MJ; Hood CL; Clancy JL; Murray DD; Méndez C; Gelgor L; Anderson B; Roth N; Cooper DA; Kelleher AD
J Immunol; 2012 Jun; 188(12):6238-46. PubMed ID: 22586040
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.
Gupta A; Swaminathan G; Martin-Garcia J; Navas-Martin S
Viruses; 2012 Oct; 4(11):2485-513. PubMed ID: 23202492
[TBL] [Abstract][Full Text] [Related]
5. Interplay between microRNAs, Toll-like receptors, and HIV-1: potential implications in HIV-1 replication and chronic immune activation.
Swaminathan G; Navas-Martín S; Martín-García J
Discov Med; 2014; 18(97):15-27. PubMed ID: 25091485
[TBL] [Abstract][Full Text] [Related]
6. miRNAs and HIV: unforeseen determinants of host-pathogen interaction.
Swaminathan S; Murray DD; Kelleher AD
Immunol Rev; 2013 Jul; 254(1):265-80. PubMed ID: 23772625
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of microRNAs in the metabolic control of immune cells.
Yao Q; Song Z; Wang B; Zhang JA
Cancer Lett; 2018 Oct; 433():10-17. PubMed ID: 29935373
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts.
Duskova K; Nagilla P; Le HS; Iyer P; Thalamuthu A; Martinson J; Bar-Joseph Z; Buchanan W; Rinaldo C; Ayyavoo V
BMC Infect Dis; 2013 May; 13():250. PubMed ID: 23721325
[TBL] [Abstract][Full Text] [Related]
9. T-cell immunometabolism against cancer.
Jiang S; Yan W
Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs and their potential involvement in HIV infection.
Sun G; Rossi JJ
Trends Pharmacol Sci; 2011 Nov; 32(11):675-81. PubMed ID: 21862142
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.
Alshahrani SH; Ibrahim YS; Jalil AT; Altoum AA; Achmad H; Zabibah RS; Gabr GA; Ramírez-Coronel AA; Alameri AA; Qasim QA; Karampoor S; Mirzaei R
Front Oncol; 2022; 12():1042196. PubMed ID: 36483029
[TBL] [Abstract][Full Text] [Related]
12. High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4
Lu X; Yang J; Wu H; Yang Z; Jin C; Wang J; Cheng L; Peng X; Liu F; Peng X; Ji S; Ou H; Xie T; Yao H; Wu N
Arch Virol; 2017 Jul; 162(7):1933-1942. PubMed ID: 28303346
[TBL] [Abstract][Full Text] [Related]
13. Identification of miRNA-mRNA crosstalk in CD4
Liao Q; Wang J; Pei Z; Xu J; Zhang X
J Transl Med; 2017 Feb; 15(1):41. PubMed ID: 28222782
[TBL] [Abstract][Full Text] [Related]
14. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.
Witwer KW; Watson AK; Blankson JN; Clements JE
Retrovirology; 2012 Jan; 9():5. PubMed ID: 22240256
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
Egaña-Gorroño L; Guardo AC; Bargalló ME; Planet E; Vilaplana E; Escribà T; Pérez I; Gatell JM; García F; Arnedo M; Plana M M;
PLoS One; 2016; 11(5):e0155245. PubMed ID: 27171002
[TBL] [Abstract][Full Text] [Related]
16. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
17. The role of microRNAs in HIV-1 pathogenesis and therapy.
Swaminathan S; Murray DD; Kelleher AD
AIDS; 2012 Jul; 26(11):1325-34. PubMed ID: 22382145
[TBL] [Abstract][Full Text] [Related]
18. In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.
Whisnant AW; Bogerd HP; Flores O; Ho P; Powers JG; Sharova N; Stevenson M; Chen CH; Cullen BR
mBio; 2013 Apr; 4(2):e000193. PubMed ID: 23592263
[TBL] [Abstract][Full Text] [Related]
19. HIV-induced cancer--all paths leading to Rome.
Zhao T; Chen W; Zhang X; Yi H; Zhao F
Microb Pathog; 2020 Feb; 139():103804. PubMed ID: 31639468
[TBL] [Abstract][Full Text] [Related]
20. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism.
Subramaniam S; Jeet V; Clements JA; Gunter JH; Batra J
Clin Chem; 2019 Sep; 65(9):1090-1101. PubMed ID: 31101638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
